Constance Horgan
Overview
Explore the profile of Constance Horgan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bowser D, Bohler R, Davis M, Hodgkin D, Horgan C
J Subst Use Addict Treat
. 2024 Jun;
165:209441.
PMID: 38906417
Background: The national opioid crisis continues to intensify, despite the fact that opioid use disorder (OUD) is treatable and opioid overdose deaths are preventable through first-line treatment with medications for...
2.
Davis M, Tschampl C, Hodgkin D, Regis C, Taveras E, Plant B, et al.
J Subst Use Addict Treat
. 2024 Jun;
164:209428.
PMID: 38879017
Introduction: People with substance use disorders (SUD) face many barriers to receiving evidence-based treatments including access to and cost of treatment. People who use drugs face stigma that limits access...
3.
Bhardwaj A, Sousa J, Huskamp H, Busch A, Kennedy-Hendricks A, Hodgkin D, et al.
Ann Fam Med
. 2023 Jul;
21(4):332-337.
PMID: 37487716
Purpose: Over 29 million Americans have alcohol use disorder (AUD). Though there are effective medications for AUD (MAUD) that can be prescribed within primary care, they are underutilized. We aimed...
4.
Davis M, Bohler R, Hodgkin D, Hamilton G, Horgan C
J Subst Use Addict Treat
. 2023 Mar;
149:209022.
PMID: 36935064
Introduction: Health plans are key players in substance use treatment in the United States, and the opioid crisis presents new challenges for them. This article is part of the HEALing...
5.
Williams A, Johnson K, Thomas C, Reif S, Socias M, Henry B, et al.
Subst Abus
. 2022 Jun;
43(1):1207-1214.
PMID: 35657670
Unintentional overdose deaths, most involving opioids, have eclipsed all other causes of US deaths for individuals less than 50 years of age. An estimated 2.4 to 5 million individuals have...
6.
Hodgkin D, Horgan C, Bart G
Addict Sci Clin Pract
. 2021 Jul;
16(1):45.
PMID: 34225785
Background: Office-Based Opioid Treatment (OBOT) is a delivery model which seeks to make medications for opioid use disorder (MOUD), particularly buprenorphine, widely available in general medical clinics and offices. Despite...
7.
Torres M, Brolin M, Panas L, Ritter G, Hodgkin D, Lee M, et al.
BMC Health Serv Res
. 2020 Nov;
20(1):1004.
PMID: 33143701
Background: Acute 24-h detoxification services (detox) are necessary but insufficient for many individuals working towards long-term recovery from opiate, alcohol or other drug addiction. Longer engagement in substance use disorder...
8.
Liu J, Storfer-Isser A, Mark T, Oberlander T, Horgan C, Garnick D, et al.
Psychiatr Serv
. 2020 Feb;
71(7):722-725.
PMID: 32089081
Objective: This study evaluated whether access to and engagement in substance use disorder treatment has improved from 2010 to 2016. Methods: Data submitted by commercial and Medicaid health plans, representing...
9.
Garnick D, Horgan C, Mark T, Lee M, Acevedo A, Neager S, et al.
Subst Abus
. 2019 Mar;
40(3):263-267.
PMID: 30913002
Identifying and effectively treating individuals with substance use disorders (SUDs) is an important priority for state Medicaid programs, given the enormous toll that SUDs take on individuals, their families, and...
10.
Quinn A, Brolin M, Stewart M, Evans B, Horgan C
Issue Brief (Mass Health Policy Forum)
. 2016 Dec;
(46):1-50.
PMID: 27911073
Risky, non-dependent alcohol use is prevalent in the United States, affecting 25% of adults (Centers for Disease Control and Prevention, 2014b). Massachusetts has higher rates of alcohol use and binge...